Another important excerpt from this:Prof Itescu said the positive response from the FDA also augured well for the company’s development platform as a whole.
The Revascor compound, for use in patients with end-stage ischaemic heart failure, is also looking good. The FDA has allowed the company to file for accelerated approval in a subset of patients at the more serious end of the disease spectrum.
banter and General Discussion, page-10882
-
- There are more pages in this discussion • 642 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.39 |
Change
0.005(0.36%) |
Mkt cap ! $1.587B | |||
| Open | High | Low | Value | Volume |
| $1.39 | $1.41 | $1.38 | $787.8K | 566.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 25143 | $1.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.40 | 1258 | 3 |
View Market Depth
| Last trade - 10.46am 11/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |